TheraRadar

Pharma Intelligence, Simplified

← Back
Data updated: Mar 10, 2026

PANGEA

ImmunologyRespiratoryDermatology
Generics

PANGEA is a generic drug manufacturer focused on Immunology, Respiratory, Dermatology.

1983
Since
6
Drugs
-
Trials
96
Approved (2yr)

Key Drugs

No active drugs

Recent Activity

CELECOXIB 2026-02-12
Labeling
OXAPROZIN 2026-01-22
Labeling
CELECOXIB 2025-10-21
Labeling
CELECOXIB 2025-10-15
Labeling
CELECOXIB 2025-10-15
Labeling
CELECOXIB 2025-09-26
Labeling
CELECOXIB 2025-09-26
Labeling
CELECOXIB 2025-09-26
Labeling
CELECOXIB 2025-08-04
Labeling
CELECOXIB 2025-07-14
SEC Filings Pro
Loading...

Therapeutic Focus

Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5

Immunology 40%
2 drugs
Respiratory 20%
1 drugs
Dermatology 20%
1 drugs
Neurology 20%
1 drugs

Pipeline Strength Pro

Loading...

Competitors Pro

GSK big-pharma
Respiratory, Immunology, Neurology
Eli Lilly big-pharma
Immunology, Neurology, Dermatology
Roche big-pharma
Neurology, Immunology, Respiratory
PHARMACIA AND UPJOHN big-pharma
Dermatology, Respiratory, Immunology
Pfizer big-pharma
Dermatology, Immunology